Emergency room administration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedure outcomes - 03/09/11
Doi : 10.1016/S0002-9149(01)01587-9
Donald E. Cutlip, MD a, ⁎ 
, Christopher J. Cove, MD a, David Irons, MD a, Vijay Kalaria, MD a, Mimi Le, MD a, Heather Cronmiller, RN, BSN a, Lori Caufield, RN, BSN a, Richard M. Pomerantz, MD a, Frederick S. Ling, MD a
, Christopher J. Cove, MD a, David Irons, MD a, Vijay Kalaria, MD a, Mimi Le, MD a, Heather Cronmiller, RN, BSN a, Lori Caufield, RN, BSN a, Richard M. Pomerantz, MD a, Frederick S. Ling, MD a a Department of Medicine and Cardiology Unit, University of Rochester Medical Center, Rochester, New York, USA
*Dr. Cutlip’s address is: Cardiology Unit, Box 679, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642
 | This study was supported by an educational grant from COR Therapeutics, South San Francisco, California. |
© 2001
Excerpta Medica Inc. Tous droits réservés.
Vol 88 - N° 1
P. 62-64 - juillet 2001 Retour au numéro
Article précédent
- Metabolic effects of high-protein, low-carbohydrate diets
- Margo A Denke
- Excellent prognosis in patients with unstable angina pectoris classified as “low risk” at admission despite presence of severe coronary artery disease
- Lene Holmvang, Birgit Jurlander, Paul Leibrandt, Avery Ellis, Galen Wagner
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?